Anika Therapeutics Inc
ANIK10.460USD
+0.160+1.55%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
150.84MMarket Cap
LossP/E TTM
More Details of Anika Therapeutics Inc Company
Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.
Anika Therapeutics Inc Info
Ticker SymbolANIK
Company nameAnika Therapeutics Inc
IPO dateMay 16, 1985
CEOBlanchard (Cheryl Renee)
Number of employees288
Security typeOrdinary Share
Fiscal year-endMay 16
Address32 Wiggins Ave
CityBEDFORD
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01730-2315
Phone17814579000
Websitehttps://anika.com/
Ticker SymbolANIK
IPO dateMay 16, 1985
CEOBlanchard (Cheryl Renee)
Company Executives of Anika Therapeutics Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+14164.00%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+14164.00%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+14164.00%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+14164.00%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
9.07K
+9071.00%
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Susan L. N. Vogt
Ms. Susan L. N. Vogt
Independent Director
Independent Director
--
--
Mr. David B. Colleran, J.D.
Mr. David B. Colleran, J.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
--
--
Mr. John Bell (Jack) Henneman, III
Mr. John Bell (Jack) Henneman, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Stephen O. Richard
Mr. Stephen O. Richard
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+14164.00%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+14164.00%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+14164.00%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+14164.00%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
9.07K
+9071.00%
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
OEM Channel
15.84M
56.96%
Commercial Channel
11.97M
43.04%
By RegionUSD
Name
Revenue
Proportion
United States
17.45M
62.72%
Europe
5.67M
20.38%
Other
4.70M
16.91%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
OEM Channel
15.84M
56.96%
Commercial Channel
11.97M
43.04%
Shareholding Stats
Updated: Sat, Feb 7
Updated: Sat, Feb 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Caligan Partners, LP
9.95%
BlackRock Institutional Trust Company, N.A.
6.38%
The Vanguard Group, Inc.
5.40%
BlackRock Financial Management, Inc.
5.38%
Acadian Asset Management LLC
4.39%
Other
68.49%
Shareholders
Shareholders
Proportion
Caligan Partners, LP
9.95%
BlackRock Institutional Trust Company, N.A.
6.38%
The Vanguard Group, Inc.
5.40%
BlackRock Financial Management, Inc.
5.38%
Acadian Asset Management LLC
4.39%
Other
68.49%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
27.66%
Investment Advisor
25.57%
Hedge Fund
20.33%
Individual Investor
4.88%
Research Firm
2.02%
Pension Fund
0.52%
Bank and Trust
0.11%
Venture Capital
0.09%
Other
18.81%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
245
12.37M
97.19%
-666.00
2025Q3
267
12.37M
100.32%
-461.27K
2025Q2
295
12.88M
103.23%
-71.30K
2025Q1
297
12.95M
103.38%
-1.70M
2024Q4
298
12.83M
102.20%
-560.99K
2024Q3
297
13.48M
104.72%
-150.44K
2024Q2
301
13.64M
105.78%
+30.78K
2024Q1
301
13.61M
105.08%
-1.78M
2023Q4
304
13.45M
105.34%
+303.47K
2023Q3
297
13.16M
105.14%
-356.42K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Caligan Partners, LP
1.44M
9.95%
--
--
Nov 19, 2025
BlackRock Institutional Trust Company, N.A.
920.60K
6.38%
-16.70K
-1.78%
Sep 30, 2025
The Vanguard Group, Inc.
780.66K
5.41%
+1.19K
+0.15%
Sep 30, 2025
BlackRock Financial Management, Inc.
776.43K
5.38%
+230.31K
+42.17%
Sep 30, 2025
Acadian Asset Management LLC
632.79K
4.39%
+57.15K
+9.93%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
601.16K
4.17%
-21.92K
-3.52%
Sep 30, 2025
Boothbay Fund Management, LLC
539.64K
3.74%
+10.14K
+1.91%
Sep 30, 2025
Renaissance Technologies LLC
533.02K
3.7%
+5.80K
+1.10%
Sep 30, 2025
The Capital Management Corporation
551.25K
3.82%
+142.40K
+34.83%
Sep 30, 2025
Geode Capital Management, L.L.C.
335.68K
2.33%
+14.47K
+4.50%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco NASDAQ Future Gen 200 ETF
0.56%
Royce Quant Small-Cap Quality Value ETF
0.2%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.1%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
WisdomTree US SmallCap Fund
0.01%
iShares Russell 2000 Value ETF
0.01%
View more
Invesco NASDAQ Future Gen 200 ETF
Proportion0.56%
Royce Quant Small-Cap Quality Value ETF
Proportion0.2%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proportion0.1%
iShares Micro-Cap ETF
Proportion0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proportion0.01%
Avantis US Small Cap Equity ETF
Proportion0.01%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.01%
WisdomTree US SmallCap Fund
Proportion0.01%
iShares Russell 2000 Value ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
